Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

Clinical trial NCT03110640 · UNKNOWN

Trial details

NCT number: NCT03110640
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Adult Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Adult Acute Lymphoblastic Leukemia in Remission Hematopoietic/Lymphoid Cancer Refractory Chronic Lymphocytic Leukemia

Start date: 2016-10-01
Primary completion: 2020-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.